{"version":"1.0","provider_name":"Breakthrough T1D","provider_url":"https:\/\/breakthrought1d.eu\/nl","author_name":"ylt-admin","author_url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/author\/ylt-admin\/","title":"Inhaleerbare insuline Afrezza opnieuw op de markt gebracht. - Breakthrough T1D","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"7jv2EpQSZ1\"><a href=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/inhaleerbare-insuline-afrezza-opnieuw-op-markt-gebracht\/\">Inhaleerbare insuline Afrezza opnieuw op de markt gebracht.<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/inhaleerbare-insuline-afrezza-opnieuw-op-markt-gebracht\/embed\/#?secret=7jv2EpQSZ1\" width=\"600\" height=\"338\" title=\"&#8220;Inhaleerbare insuline Afrezza opnieuw op de markt gebracht.&#8221; &#8212; Breakthrough T1D\" data-secret=\"7jv2EpQSZ1\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/breakthrought1d.eu\/nl\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","description":"De inhaleerbare vorm van insuline, Afrezza, wordt opnieuw op de markt gebracht door Mannkind. Eerder heeft Sanofi geprobeerd deze vorm van insuline op de markt te brengen, echter mislukte dit. Daarom probeert Mannkind deze insuline opnieuw op de markt te brengen. \u201cEr hangen meer voordelen dan alleen de afwezigheid van naalden aan deze insuline. Afrezza [&hellip;]","thumbnail_url":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/09\/afrezza-150x150-1.jpg"}